Management tracks: Batu, Halozyme, FOG

Immunotherapy company Batu Biologics Inc., (San Diego, Calif.) said founder Thomas Ichim has become president and CEO. Ichim, also a director, was previously Batu's CSO. He succeeds founder Samuel Wagner, who stepped down and remains a board member.

Cancer company Halozyme Therapeutics Inc. (NASDAQ: HALO) hired Alison Armour as SVP of research and development. Armour was CMO of Endocyte Inc., which is now part of Novartis AG (NYSE:NVS; SIX:NOVN)...